FDA Inspection 1173726 — American Blood Bank Corp.
The FDA completed an inspection of American Blood Bank Corp. on Jun 14, 2022 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 14, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Miami, FL (United States)